DalsnaFinance

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

Stocks Investing.com Canada By Investing.com Canada 13 Jul 2026 12:52 1 min read
BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake  Investing.com Canada

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake Investing.com Canada

Read the full story on Investing.com Canada → Opens the original article on news.google.com

Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.